Cite
MLA Citation
Andreas Sashegyi et al.. “Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.” Journal of chemotherapy, vol. 29, 2017, pp. 62–64. http://access.bl.uk/ark:/81055/vdc_100040164858.0x00001e